IDO inhibitor Market Insights Video

According to Cognitive Market Research, the global IDO Inhibitor market size was USD 10685.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 19.80% from 2024 to 2031.

• North America held the major market share for more than 40% of the global revenue with a market size of USD 4274.20 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.0% from 2024 to 2031.
• Europe accounted for a market share of over 30% of the global revenue with a market size of USD 3205.65 million.
• Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 2457.67 million in 2024 and will grow at a compound annual growth rate (CAGR) of 21.8% from 2024 to 2031.
• Latin America had a market share of more than 5% of the global revenue with a market size of USD 534.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.2% from 2024 to 2031.
• Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 213.71 million in 2024 and will grow at a compound annual growth rate (CAGR) of 19.5% from 2024 to 2031.
• The dual IDO1/TDO inhibitors is the fastest growing segment of the IDO Inhibitor industry